{"product_id":"9783032304995","title":"Translational Research Methods for the Metabolic Continuum A Focus on Early Phase Clinical Drug Development","description":"\u003ch1\u003eTranslational Research Methods for the Metabolic Continuum\u003c\/h1\u003e\u003ch2\u003eA Focus on Early Phase Clinical Drug Development\u003c\/h2\u003e\u003ch3\u003eAndrew J. Krentz | Marcus Hompesch\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Diseases\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\u003c\/div\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cb\u003eAndrew J. Krentz M.D\u003c\/b\u003e. - Andrew holds the position of Senior Research Fellow at ProSciento, Inc.  His experience as a researcher – gained in the UK and USA – has ranged from human metabolism to epidemiology to preclinical and early-phase clinical cardiometabolic drug development.  His M.D. research thesis was titled Metabolic Studies in Insulin Resistance.  His professional accolades include honorary Fellowship of the Faculty of Pharmaceutical Medicine (FFPM) of the Royal College of Physicians of London in recognition of ‘outstanding contributions to pharmaceutical medicine’ and Fellowship of the Royal College of Pathologists (FRCPath) on the strength of his publications in the field of chemical pathology-clinical biochemistry. He is recognised as a clinical specialist by the European Society of Hypertension. He serves on the Medical, Scientific \u0026amp; Research Committee of HEART UK and is President of Vascular, Lipid \u0026amp; Metabolic Medicine at the Royal Society of Medicine, London, UK.  \u003c\/p\u003e\r\n\r\n\u003cp\u003eProfessor Krentz has held senior positions within the NHS, academia, and the life sciences.  He currently holds visiting chairs in the School of Population Health Sciences at King’s College London and at the Institute of Cardiovascular \u0026amp; Metabolic Research at the University of Reading, UK. His recent textbooks include: \u003ci\u003eKrentz A.J., Weyer C., Hompesch M. (Eds) Translational Research Methods in Diabetes, Obesity and Nonalcoholic Fatty Liver Disease: Focus on Early Phase Clinical Drug Development. Springer 2019\u003c\/i\u003e; \u003ci\u003eKrentz A.J. \u0026amp; Chilton R. (eds). Cardiovascular Endocrinology \u0026amp; Metabolism: Theory \u0026amp; Practice of Cardiometabolic Medicine. Academic Press, 2023 In press; Krentz A.J. (Ed). Insulin@100: Deficiency, Excess \u0026amp; Resistance in Human Disease. Academic Press, 2023 in press\u003c\/i\u003e.  Professor Krentz is the founding editor-in-chief of the interdisciplinary scientific journal Cardiovascular Endocrinology \u0026amp; Metabolism (www.cardiovascularendocrinology.com). \u003c\/p\u003e\r\n\r\n\u003cp\u003e \u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cb\u003eMarcus Hompesch M.D. –\u003c\/b\u003e Dr. Marcus Hompesch is Chief Executive Officer and Chairman of the Board of ProSciento and has led the company since its inception in 2003. He is also editor-in-chief of the journal Endocrinology, Diabetes \u0026amp; Metabolism, a Wiley publication. His career and track record in metabolism-focused clinical R\u0026amp;D, spanning more than 25 years in academic and industry settings, includes contributions to clinical development strategies and early phase research studies for many of the diabetes and related metabolic drugs and devices on the market globally. Prior to leading ProSciento, Dr. Hompesch was Chief Operating Officer of Profil Institut für Stoffwechselforschung GmbH and, before that, was founder and Chief Executive Officer of the medical technology company Med.IQ. He is an author of more than 100 publications, including peer-reviewed journals and editorials and is a regular peer reviewer for scientific journals relevant to metabolic diseases. He is also an editor and co-author of the textbook Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. As a licensed physician in Europe he received his M.D. from the University of Düsseldorf, Germany, and following medical school trained in internal medicine and diabetology at the Klinikum Wuppertal Medical Center. He also was a scientific associate at the Department of Medical Informatics, Bio-Statistics and Epidemiology at the Ruhr University Bochum, Germany.\u003c\/p\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e30 August 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eSpringer Nature Switzerland\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eSpringer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783032304995\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e662\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Springer Nature Switzerland","offers":[{"title":"Default Title","offer_id":50300902867084,"sku":"9783032304995","price":197.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9783032304995","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}